An interventional study of Additioned Endoscopy in ERCP, sponsored by Changhai Hospital. Status unknown at 1 site in China. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2017-11-22.
Sponsored by Changhai Hospital · Not applicable, Interventional, and Other
Validation of clinical use of additioned endoscopy in Endoscopic Retrograde Cholangiopancreatography(ERCP) treatment.
Investigators recently developed a device named additioned Endoscopy. The purpose of current clinical trial is to evaluate the use of additioned endoscopy in ERCP treatment, specifically in shortening the duration of ERCP operation and lowering incidence of complications.
Exclusion Criteria:
This arm will include participants undergoing ERCP with assistance of additioned endoscopy.
Device: Additioned Endoscopy
This arm will include participants undergoing ERCP without assistance of additioned endoscopy as negative controls.
To evaluate the use of additioned endoscopy in ERCP treatment.
Duration of ERCP treatment
To test if additioned endoscopy will have impact on duration of ERCP treatment
Time frame: Duration of operation in each patient, ie. from beginning to the end of ERCP operation in each patient
complications of ERCP treatment
To test if additioned endoscopy will have impact on incidence of ERCP complications, including perforation, bleeding, post-ERCP pancreatitis.
Time frame: up to 1 month after ERCP completion
Plan to share: No
No publications or documents are linked to this record.
This study is status unknown, as verified in Nov 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Changhai Hospital